Targeted Therapy
What Is an Antibody-Drug Conjugate (ADC)? The Precision Oncology Technology Reshaping Cancer Treatment
Antibody-drug conjugates — universally known in biotech as ADCs — have become one of the most commercially successful and scientifically active areas of oncology drug development. With multiple blockbuster ADCs on the market and billions in pharmaceutical deal-making driven by ADC pipeline acquisitions, understanding what ADC technology is, how it works, and why the pharmaceutical…
What Is a Drug’s Mechanism of Action? A Plain English Guide for Biotech Investors
Every biotech press release describing a drug in clinical development includes at least a brief description of the drug’s mechanism of action. Yet for many retail investors, this section gets skimmed — it reads like jargon, and the significance of the underlying science is not always obvious. Understanding what mechanism of action means, why it…
